Q3 2017 Holdings
Filed 2017-11-13 | 29 holdings | $166.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics(ACRS) | Common | 00461U105 | $73.8M | 2,858,569 | 44.4% |
| Ascendis Pharma(ASND) | ADR | 04351P101 | $64.0M | 1,766,832 | 38.6% |
| Codexis, Inc.(CDXS) | Common | 192005106 | $20.3M | 3,054,825 | 12.2% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $7.6M | 1,213,290 | 4.6% |
| Biohaven Pharmaceutical Holding Company Ltd(BHVN) | Common | G11196105 | $73.9K | 1,976,818 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637105 | $33.4K | 4,074,190 | 0.0% |
| Kala Pharmaceuticals Inc. | Common | 483119103 | $26.5K | 1,158,911 | 0.0% |
| Verona Pharma Plc(VRNA) | ADS | 925050106 | $22.9K | 1,492,951 | 0.0% |
| Strongbridge Biopharma plc | Ordinary Shares | G85347105 | $20.4K | 2,962,645 | 0.0% |
| Selecta Biosciences, Inc.(SELBUSD) | Common | 816212104 | $20.4K | 1,119,189 | 0.0% |
| Eiger BioPharmaceuticals(CLDNEUR) | Common | 28249U105 | $19.7K | 1,787,091 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | Common | 00900T107 | $19.3K | 776,813 | 0.0% |
| Advanced Accelerator Applications S.A. | ADS | 00790T100 | $16.9K | 249,241 | 0.0% |
| Kadmon Holdings, Inc.(KDMN) | Common | 48283N106 | $11.2K | 3,333,333 | 0.0% |
| Amyris(AMRSEUR) | Common | 03236M200 | $9.0K | 2,826,711 | 0.0% |
| Zai Lab(ZLAB) | ADR | 98887Q104 | $8.8K | 325,000 | 0.0% |
| Soleno Therapeutics, Inc. | Common | 834203101 | $7.6K | 14,695,264 | 0.0% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common | 00847L100 | $6.8K | 1,513,975 | 0.0% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $5.4K | 164,403 | 0.0% |
| Foamix Pharmaceuticals Ltd. | SHS | M46135105 | $4.7K | 855,000 | 0.0% |
| Trevena, Inc. | Common | 89532E109 | $4.4K | 1,728,000 | 0.0% |
| BioPharmX Corporation | Common | 09072X101 | $4.0K | 14,096,338 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U107 | $3.8K | 2,438,270 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $2.7K | 148,878 | 0.0% |
| ReVance Therapeutics, Inc.(RVNCEUR) | Common | 761330109 | $2.1K | 77,373 | 0.0% |
| Akari Therapeutics Plc | ADR | 00972G108 | $2.1K | 345,850 | 0.0% |
| KalVista Pharmaceuticals, Inc.(KALV) | Common | 483497103 | $2.0K | 300,325 | 0.0% |
| Sunesis Pharmaceuticals, Inc. | Common | 867328700 | $970 | 500,000 | 0.0% |
| Soleno Therapeutics, Inc. (W) | Warrant | 834203119 | $112 | 943,858 | 0.0% |